![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(η6-p-cymene)Cl2(pta)) | Anti-cancer Agent,](https://www.mdpi.com/ijms/ijms-13-13183/article_deploy/html/images/ijms-13-13183f1.png)
glutathione rapta c
glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(η6-p-cymene)Cl2(pta)) | Anti-cancer Agent,
RAPTA C (Ru(6 p cymene)Cl2(pta)) Anti cancer Agent, Anti angiogenic Agent MedChemExpress Glutathione comp Structural variations of the ligands in the lead compound RAPTA C. Download Scientific Diagram Anti cancer organoruthenium( ii ) complexes and their interactions with cysteine and its analogues. A mass spectrometric study Dalton Transactions (RSC Publishing) DOI:10.1039 C8DT04350G Enhanced Delivery of the RAPTA C Macromolecular Chemotherapeutic by Conjugation to Degradable Polymeric Micelles Biomacromolecules The structural formulas of RAPTA C (left) and herein reported complexes Download Scientific Diagram
USD23.67
USD48.67
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(6-p-cymene)Cl2(pta)) | Anti-cancer Agent,](https://file.medchemexpress.com/product_pic/hy-130326.gif)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(6-p-cymene)Cl2(pta)) | Anti-cancer Agent,](https://drreinwald.com/wp-content/uploads/2025/11/Glutathion_EN-835x1024.png)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(6-p-cymene)Cl2(pta)) | Anti-cancer Agent,](https://www.researchgate.net/publication/44579667/figure/fig4/AS:349450833809419@1460326979428/Structural-variations-of-the-ligands-in-the-lead-compound-RAPTA-C.png)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(6-p-cymene)Cl2(pta)) | Anti-cancer Agent,](https://pubs.rsc.org/image/article/2019/DT/c8dt04350g/c8dt04350g-u2_hi-res.gif)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(6-p-cymene)Cl2(pta)) | Anti-cancer Agent,](https://pubs.acs.org/cms/10.1021/bm4013919/asset/images/medium/bm-2013-013919_0011.gif)
![glutathione rapta c Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6-p-phenylethacrynate)Cl2(pta)] RAPTA-C (Ru(6-p-cymene)Cl2(pta)) | Anti-cancer Agent,](https://www.researchgate.net/profile/Lucie-Hanouskova-2/publication/284718542/figure/fig1/AS:340779944955930@1458259678678/The-structural-formulas-of-RAPTA-C-left-and-herein-reported-complexes-1-8-right-The.png)